Paul Audhya
Director Técnico/Científico/I+D en KALVISTA PHARMACEUTICALS, INC. .
Fortuna: 737 709 $ al 30/04/2024
Cargos activos de Paul Audhya
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KALVISTA PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 03/05/2021 | - |
Historial de carrera de Paul Audhya
Antiguos cargos conocidos de Paul Audhya.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ARENA PHARMACEUTICALS | Corporate Officer/Principal | 26/11/2018 | 01/03/2021 |
VERTEX PHARMACEUTICALS INCORPORATED | Director Técnico/Científico/I+D | 01/02/2016 | 01/09/2018 |
HOSPIRA, INC. | Director Técnico/Científico/I+D | 01/06/2013 | 01/02/2016 |
REATA PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 04/07/2011 | - |
Formación de Paul Audhya.
New York University | Undergraduate Degree |
Pepperdine University | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Chief Tech/Sci/R&D Officer | 4 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
KALVISTA PHARMACEUTICALS, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
Empresas privadas | 3 |
---|---|
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Paul Audhya
- Experiencia